01 / Contract Profile
75A50122C00072 Federal Contract Award
Agency code 7505
THE PURPOSE OF THIS MODIFICATION IS TO EXTEND CLIN0001/BASE THROUGH DECEMBER 31, 2026, PROVIDE SUPPLEMENTAL FUNDING TO SUPPORT THE DEVELOPMENT OF INTRAMUSCULAR (IM) ENA-001 FOR SUBMISSION TO THE US FOOD AND DRUG ADMINISTRATION, UPDATE SECTION I.1 FED
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50122C00072 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$810.1K
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2022 | $5.96M | 1 | — |
| FY 2023 | $469.3K | 2 | −92.1% |
| FY 2024 | $4.97M | 2 | +960.0% |
| FY 2025 | $0 | 1 | −100.0% |
| FY 2026 | $810.1K | 1 | — |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | BARDA - ASPR / DAAPPO / BARDA DCMA |
05 / Contractor
Who holds this federal contract?
ENALARE THERAPEUTICS INC
UEI MDJFW877BCV6 · CAGE 8G2D2
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $12.21M | 7 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $12.21M | 7 | 100.0% |
08 / Place of Performance
Where is the work recorded?
PRINCETON, MERCER, NEW JERSEY, UNITED STATES
ZIP 085403013
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| May 18, 2026 | P00006 | $810.1K | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Dec 15, 2025 | P00005 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 5, 2024 | P00004 | $4.97M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Mar 25, 2024 | P00003 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 30, 2023 | P00002 | $0 | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 20, 2023 | P00001 | $469.3K | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
| Sep 22, 2022 | Base action | $5.96M | BARDA - ASPR / DAAPPO / BARDA DCMAOffice code 75A501 | 541714 | AN13 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.